Switch from Risperidone to Perospirone in Patients with Chronic Schizophrenia

By Fujita K.  

Clinical Drug Investigation, Vol. 24, Iss. 5, 2004-01 ,pp. : 295-299

Adis International

Access to resources Recommend Favorite

Is the Time Course of Clozapine Response Correlated to the Time Course of Clozapine Plasma Levels? A One-Year Prospective Study in Drug-Resistant Patients with Schizophrenia

By Fabrazzo M.   La Pia S.   Monteleone P.   Esposito G.   Pinto A.   De Simone L.   Bencivenga R.   Maj M.  

Neuropsychopharmacology, Vol. 27, Iss. 6, 2002-12 ,pp. : 1050-1055

Elsevier

Access to resources Recommend Favorite

Prediction of changes in memory performance by plasma homovanillic acid levels in clozapine-treated patients with schizophrenia

By Sumiyoshi Tomiki   Roy A.   Kim C.-H.   Jayathilake K.   Lee M.   Sumiyoshi C.   Meltzer H.  

Psychopharmacology, Vol. 177, Iss. 1-2, 2004-12 ,pp. : 79-83

Springer Publishing Company

Access to resources Recommend Favorite

Effect of clozapine on serum leptin, insulin levels, and body weight and composition in patients with schizophrenia

By Kivircik B.B.   Alptekin K.   Caliskan S.   Comlekci A.   Oruk G.   Tumuklu M.   Kurklu K.   Arkar H.   Turk A.   Caliskan M.   Yesil S.  

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Iss. 5, 2003-08 ,pp. : 795-799

Elsevier

Access to resources Recommend Favorite

Effects of clozapine on plasma monoamine metabolites in treatment-refractory schizophrenic patients

By Min-Soo L.   Seung-Hyun K.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 341-342

Elsevier

Access to resources Recommend Favorite